222 related articles for article (PubMed ID: 31696836)
1. Efficacy and safety of low-intensity shockwave therapy plus tadalafil 5 mg once daily in men with type 2 diabetes mellitus and erectile dysfunction: a matched-pair comparison study.
Verze P; Capece M; Creta M; La Rocca R; Persico F; Spirito L; Cardi A; Mirone V
Asian J Androl; 2020; 22(4):379-382. PubMed ID: 31696836
[TBL] [Abstract][Full Text] [Related]
2. The effect of combination treatment with low-intensity shockwave therapy and daily tadalafil on severe erectile dysfunction: a double-blind, randomized, sham-controlled clinical trial.
Kalyvianakis D; Mykoniatis I; Pyrgidis N; Kapoteli P; Zilotis F; Hatzichristou D
J Sex Med; 2024 May; 21(6):533-538. PubMed ID: 38600694
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Combination Therapies vs Monotherapy for Erectile Dysfunction: A Systematic Review and Meta-analysis.
Mykoniatis I; Pyrgidis N; Sokolakis I; Ouranidis A; Sountoulides P; Haidich AB; van Renterghem K; Hatzichristodoulou G; Hatzichristou D
JAMA Netw Open; 2021 Feb; 4(2):e2036337. PubMed ID: 33599772
[TBL] [Abstract][Full Text] [Related]
4. The Role of the Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Radical Prostatectomy: A Randomized Clinical Trial.
Baccaglini W; Pazeto CL; Corrêa Barros EA; Timóteo F; Monteiro L; Saad Rached RY; Navas A; Glina S
J Sex Med; 2020 Apr; 17(4):688-694. PubMed ID: 32007430
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of low-intensity shockwave therapy with different tadalafil regimens in patients with PDE5 inhibitor-resistant erectile dysfunction: a retrospective cohort study.
İbis MA; Ozkaya F; Tokatli Z; Akpinar C; Yaman O
Int Urol Nephrol; 2024 Feb; 56(2):407-413. PubMed ID: 37751053
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the efficacy of combination therapy with folic acid and tadalafil for the management of erectile dysfunction in men with type 2 diabetes mellitus.
Hamidi Madani A; Asadolahzade A; Mokhtari G; Shahrokhi Damavand R; Farzan A; Esmaeili S
J Sex Med; 2013 Apr; 10(4):1146-50. PubMed ID: 23347176
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant daily therapy with L-arginine 2,500 mg and tadalafil 5 mg increases efficacy and duration of benefits of low-intensity extracorporeal shock wave therapy for erectile dysfunction: A prospective, randomized, single-blinded study with 1-year follow-up.
Gallo L; Pecoraro S; Sarnacchiaro P
Investig Clin Urol; 2022 Jan; 63(1):83-91. PubMed ID: 34983126
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of low-intensity extracorporeal shock wave therapy versus on-demand tadalafil for erectile dysfunction.
Zanaty F; Badawy A; Kotb H; Elsarfy F; Salman B
Arab J Urol; 2022; 20(4):189-194. PubMed ID: 36353469
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Combination Treatment With Low-Intensity Shockwave Therapy and Tadalafil on Mild and Mild-To-Moderate Erectile Dysfunction: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.
Mykoniatis I; Pyrgidis N; Zilotis F; Kapoteli P; Fournaraki A; Kalyvianakis D; Hatzichristou D
J Sex Med; 2022 Jan; 19(1):106-115. PubMed ID: 34866029
[TBL] [Abstract][Full Text] [Related]
10. Low-Intensity Shockwave Therapy for Erectile Dysfunction: A Randomized Clinical Trial Comparing 2 Treatment Protocols and the Impact of Repeating Treatment.
Kalyvianakis D; Memmos E; Mykoniatis I; Kapoteli P; Memmos D; Hatzichristou D
J Sex Med; 2018 Mar; 15(3):334-345. PubMed ID: 29396020
[TBL] [Abstract][Full Text] [Related]
11. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
Porst H; Gacci M; Büttner H; Henneges C; Boess F
Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
[TBL] [Abstract][Full Text] [Related]
12. Effects of taking tadalafil 5 mg once daily on erectile function and total testosterone levels in patients with metabolic syndrome.
Ozcan L; Polat EC; Kocaaslan R; Onen E; Otunctemur A; Ozbek E
Andrologia; 2017 Nov; 49(9):. PubMed ID: 28295481
[TBL] [Abstract][Full Text] [Related]
13. Durability of response following cessation of tadalafil taken once daily as treatment for erectile dysfunction.
Porst H; Glina S; Ralph D; Zeigler H; Wong DG; Woodward B
J Sex Med; 2010 Oct; 7(10):3487-94. PubMed ID: 20584129
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of clinical efficacy, safety and patient satisfaction rate after low-intensity extracorporeal shockwave therapy for the treatment of male erectile dysfunction: an Australian first open-label single-arm prospective clinical trial.
Chung E; Cartmill R
BJU Int; 2015 Apr; 115 Suppl 5():46-9. PubMed ID: 25828173
[TBL] [Abstract][Full Text] [Related]
15. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
Giuliano F; Oelke M; Jungwirth A; Hatzimouratidis K; Watts S; Cox D; Viktrup L
J Sex Med; 2013 Mar; 10(3):857-65. PubMed ID: 23346990
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the long-term safety and effectiveness of tadalafil once daily in Chinese men with erectile dysfunction: interim results of a multicenter, randomized, open-label trial.
Jiang H; Zhao LM; Lin HC; Yan S; Liu JH; Zhu ZH; Luo JD; Dai YT; Li FB; Lou Y; Zhang ZC
Asian J Androl; 2018; 20(6):587-592. PubMed ID: 30004039
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
Kim SW; Park NC; Lee SW; Yang DY; Park JK; Moon DG; Yang SK; Lee SW; Moon KH; Ahn TY; Kim SW; Park K; Min KS; Ryu JK; Son H; Jung J; Hyun JS
J Sex Med; 2017 Aug; 14(8):1018-1027. PubMed ID: 28760246
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases.
Brock G; Ni X; Oelke M; Mulhall J; Rosenberg M; Seftel A; D'Souza D; Barry J
J Sex Med; 2016 May; 13(5):860-75. PubMed ID: 27114197
[TBL] [Abstract][Full Text] [Related]
19. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
[TBL] [Abstract][Full Text] [Related]
20. Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.
Glina S; Roehrborn CG; Esen A; Plekhanov A; Sorsaburu S; Henneges C; Büttner H; Viktrup L
J Sex Med; 2015 Jan; 12(1):129-38. PubMed ID: 25353053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
